Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Repaglinide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Repaglinide 1mg tablets
0601023R0AAABAB
|
Repaglinide | Repaglinide | Endocrine System | 4,371 |
|
Repaglinide 2mg tablets
0601023R0AAACAC
|
Repaglinide | Repaglinide | Endocrine System | 3,832 |
|
Repaglinide 500microgram tablets
0601023R0AAAAAA
|
Repaglinide | Repaglinide | Endocrine System | 3,755 |
|
Prandin 2mg tablets
0601023R0BCACAC
|
Prandin | Repaglinide | Endocrine System | 33 |
|
Prandin 1mg tablets
0601023R0BCABAB
|
Prandin | Repaglinide | Endocrine System | 26 |
|
Prandin 0.5mg tablets
0601023R0BCAAAA
|
Prandin | Repaglinide | Endocrine System | 9 |
|
Enyglid 0.5mg tablets
0601023R0BDAAAA
|
Enyglid | Repaglinide | Endocrine System | No data available |
|
Enyglid 1mg tablets
0601023R0BDABAB
|
Enyglid | Repaglinide | Endocrine System | No data available |
|
Enyglid 2mg tablets
0601023R0BDACAC
|
Enyglid | Repaglinide | Endocrine System | No data available |
|
NovoNorm 1mg tablets
0601023R0BBABAB
|
NovoNorm | Repaglinide | Endocrine System | No data available |
|
NovoNorm 2mg tablets
0601023R0BBACAC
|
NovoNorm | Repaglinide | Endocrine System | No data available |
|
NovoNorm 500microgram tablets
0601023R0BBAAAA
|
NovoNorm | Repaglinide | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.